ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$BCRX:NASDAQ · BIOCRYST PHARMACEUTICALS INC

Sector: health

Conviction from: NASDAQ

52-week range: 6.0011.22

Rare-disease drug developer (hereditary angioedema)

4 tracked filer(s) hold this · 2 opened, 1 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 62 — mean of 4 scored holder(s) · buyers (new/add) avg 64. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Louis Bacon / Moore53New buy848,336$8,483,3600.1%
Steve Cohen / Point7276New buy260,917$2,609,1700.0%
Paul Tudor Jones / Tudor63Added +198%285,028$2,850,2800.0%
Bridgewater56Trimmed -23%491,057$4,910,5700.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-10Gilbert Cisneros CA31BUY$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.